GM
Last reporting period 30 Jun, 2024
Updated 18 Sep, 2024
Last price
—
Market cap $B
16.818
Exchange
XCSE - Nasdaq Copenhagen A/S
5 %
Last period Net income growth rate
73%
Net income growth rate has increased in 5 years
What is Net income growth rate ?
An indicator of the company's profit growth rate relative to the same periods of previous years.
See also Genmab
Company Analysis
GMAB.CO valuation, rating, competitors, insights and company profile
Eyestock Rating
GMAB.CO financial analysis by Eyestock methodology
Valuation
GMAB.CO valuation using historical relative method
Statements
GMAB.CO Income Statements, Balance Sheet and Cash Flow Statements
Dividends
GMAB.CO dividend yield and annual dividend
An indicator of the company's profit growth rate relative to the same periods of previous years.
Genmab`s Net income growth rate for the period ended 2024-06-30 is 5 %
